Marico Q1 profit rose 27% to Rs 652 crore as revenue climbed 22.9%, resurfacing an August 2026 report
Marico had reported Q1 FY27 revenue from operations of Rs 3,957 crore, versus Rs 3,221 crore a year earlier, supported by domestic volume growth, in results resurfacing from August 2026. The FMCG major was also planning to acquire a 75% stake in Vietnam-based skincare company Skinetiq for Rs 261 crore.
What happened
Marico reported strong domestic volume-led Q1 FY27 growth, with net profit rising 27% to Rs 652 crore and revenue up 22.85%. The tag page also cites its planned
Key facts
- Q1 net profit: Rs 652 crore, up 27%
- Q1 revenue from operations: Rs 3,957 crore, up 22.85%
- Prior-year Q1 revenue: Rs 3,221 crore
- Planned 75% Skinetiq acquisition: Rs 261 crore
- Q3 profit: Rs 460 crore, up 13.3%
- Q3 revenue: up 26.6%
- Another Q3 PAT: Rs 399 crore, up 4%
- Another Q3 revenue: up 15%
Why this matters
The planned Rs 261 crore acquisition of a 75% stake in Vietnam’s Skinetiq advances Marico’s international skincare expansion and adds a platform for Southeast Asian growth.
What to watch
- Domestic volume-growth trend versus reported revenue growth in the next two quarters.
- Gross-margin movement and management commentary on copra, edible oil and packaging costs.
- Skinetiq transaction closing, revenue scale, profitability and integration milestones.
- Advertising-and-promotion spend as a percentage of sales and its impact on operating margins.
- Rural demand, competitive pricing and market-share trends in coconut oil, foods and personal care.
- Complete and integrate the 75% Skinetiq acquisition, retaining local management and distribution capabilities.
- Increase marketing and innovation spending in premium skincare, digital-first beauty and value-added food categories.
- Use domestic distribution expansion and rural demand recovery to protect volume momentum.
- Take calibrated price increases or pack-size actions if copra, vegetable-oil or packaging inflation accelerates.